What is the appropriate management of mastitis in a pregnant patient?

Management of Mastitis During Pregnancy

Pregnant women with mastitis should continue regular feeding or milk expression as an adjunct to treatment, with antibiotics indicated for infectious cases, and should be monitored closely for abscess formation which occurs in approximately 10% of cases and requires drainage. 1

Initial Management Approach

The cornerstone of mastitis management during pregnancy mirrors lactational mastitis principles, even though the patient is not yet breastfeeding:

• Regular milk expression or drainage is therapeutic, not just symptomatic relief 1
• Antibiotics are indicated when infectious mastitis is suspected (presence of fever, systemic symptoms, or purulent drainage) 1
• Continue drainage from the affected breast unless purulent material would contact areas that will later be used for infant feeding 1

Key Diagnostic Considerations

Distinguish Between Infectious vs. Non-Infectious Mastitis

This distinction is critical because infectious cases require intervention while non-infectious cases need only supportive care 2. Look for:

• Fever and systemic symptoms (suggests infection)
• Purulent drainage or thick fluid collections
• Progressive symptoms despite conservative measures

Maintain High Suspicion for Atypical Presentations

Antepartum mastitis is uncommon 3, which creates several diagnostic pitfalls:

• If symptoms persist despite standard antibiotics, obtain comprehensive microbiological workup including mycobacterial cultures 4
• Monitor pus characteristics closely (color, odor, volume) as these can expedite pathogen identification 5
• Consider granulomatous mastitis if treatment-resistant; this requires core biopsy for histopathological confirmation 6, 2

Abscess Management (10% of Cases)

When abscesses develop during pregnancy:

For Collections ≤5 cm:

• Ultrasound-guided needle aspiration is first-line when technically feasible 7
• Resolution rates of 85-92% with shorter healing times compared to surgical drainage 7

For Collections >5 cm or Complex Features:

• Stab incision with drain placement (no packing) for thick fluid collections not amenable to aspiration 2
• Office-based procedure is preferred; operative drainage only if patient cannot tolerate office procedure 2
• Surgical drainage remains preferred for multiloculated or recurrent abscesses 7

Antibiotic Selection

• Minimum 10-day course when phlegmon is present 2
• Avoid metronidazole during pregnancy when possible, as it may affect the fetus and certain infections (like Prevotella bivia) can increase risks of placental abruption 5
• Target therapy based on culture results when available

Special Situations Requiring Modified Approach

Granulomatous Mastitis in Pregnancy:

If core biopsy confirms granulomatous mastitis:

• Cystic neutrophilic granulomatous mastitis (CNGM): Treat empirically with doxycycline 2
• Other GM types: No role for empiric antibiotics; avoid surgical excision 2
• Systemic corticosteroids and immunosuppressive therapy should generally be withheld during pregnancy 4, 6
• Consider intralesional steroid injections for worsening symptoms 2
• These cases can take up to 18 months to resolve and often recur 2

Mycobacterial Infections:

• Conservative management during pregnancy with drainage and supportive care 4
• Defer definitive antimycobacterial therapy until postpartum when triple therapy (rifampin, ethambutol, azithromycin) can be safely administered 4
• Always exclude tuberculosis before initiating treatment 4

Critical Pitfalls to Avoid

1. Do not delay comprehensive microbiological workup in treatment-resistant cases—this fundamentally alters management 4
2. Do not initiate immunosuppressive therapy before confirming diagnosis and excluding infectious etiologies 4
3. Do not perform repeated aspirations or surgical excision for granulomatous mastitis—this worsens outcomes 2
4. Do not pack wounds after incision and drainage—drain placement without packing is the standard 2

Postpartum Considerations

• Breastfeeding can continue on the affected side as long as the infant's mouth does not contact purulent drainage 1
• Definitive treatment for conditions requiring immunosuppression or antimycobacterial therapy should be initiated postpartum 4
• Close follow-up is essential as imaging resolution may lag behind clinical improvement by over 1 year 8